首页> 美国卫生研究院文献>OncoTargets and therapy >Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

【2h】

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

机译：唑来膦酸对绝经后乳腺癌患者接受来曲唑辅助治疗对芳香化酶抑制剂相关骨丢失的预防作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThis study aims to compare the efficacy and safety between zoledronic acid combined with calcium and calcium alone to prevent aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole.

机译：背景本研究旨在比较唑来膦酸联合钙与单独使用钙预防预防芳香化酶抑制剂引起的骨痛的绝经后乳腺癌患者接受来曲唑辅助治疗的有效性和安全性。

著录项

期刊名称 OncoTargets and therapy
作者
Shengliang Sun; Fuchao Wang; Honglei Dou; Longqiang Zhang; Jiwen Li;
展开▼
作者单位

展开▼
年(卷),期 2016(9),-1
年度 2016
页码 6029–6036
总页数 8
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
zoledronic acid breast cancer postmenopausal osteoporosis letrozole;

机译：唑来膦酸;乳腺癌;绝经后骨质疏松症;来曲唑;

相似文献

外文文献
中文文献
专利

1. Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole [J] . Shengliang Sun, Fuchao Wang, Honglei Dou, OncoTargets and therapy . 2016,第2期

机译：唑来膦酸对绝经后乳腺癌患者接受来曲唑辅助治疗对芳香化酶抑制剂相关骨丢失的预防作用
2. Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results. [J] . Brufsky AM, Bosserman LD, Caradonna RR, Clinical breast cancer . 2009,第2期

机译：唑来膦酸可有效地预防接受来曲唑辅助治疗的绝经后早期乳腺癌妇女的芳香化酶抑制剂相关的骨丢失：Z-FAST研究36个月的随访结果。
3. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: zO-FAST study results. [J] . Bundred NJ, Campbell ID, Davidson N, Cancer: A Journal of the American Cancer Society . 2008,第5期

机译：唑来膦酸能有效抑制接受来曲唑辅助治疗的绝经后早期乳腺癌女性的芳香化酶抑制剂相关的骨丢失：zO-FAST研究结果。
4. Bone Density Changes during Adjuvant Aromatase Inhibitor Treatment in Breast Cancer Patients: Single Centre Experience [C] . World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：乳腺癌患者辅助芳香化酶抑制剂治疗期间的骨密度变化：单中心经验。
5. The Genetics of Aromatase Inhibitor-related Phenotypes in Postmenopausal Women with ER+ Breast Cancer [D] . Dudenkov, Tanda Tosia Murray. 2017

机译：ER +乳腺癌绝经后妇女芳香酶抑制剂相关表型的遗传
6. 5-year Follow-up of a Randomized Controlled Trial of Immediate versus Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letrozole after Tamoxifen: N03CC (Alliance) [O] . Nina D. Wagner-Johnston, Jeff A. Sloan, Heshan Liu, -1

机译：5年随访的即刻和延迟唑来膦酸随机对照试验用于预防在他莫昔芬后开始来曲唑治疗的绝经后乳腺癌患者的骨丢失：N03CC（联盟）
7. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results [O] . Bundred Nigel J, Campbell Ian D, Davidson Neville, 2008

机译：唑来膦酸可有效抑制接受来曲唑辅助治疗的绝经后早期乳腺癌女性的芳香化酶抑制剂相关的骨丢失：ZO-FAST研究结果

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

摘要

著录项

相似文献

相关主题

期刊订阅